Author: Ewers, Michael; Ioannidis, John P.A.; Plesnila, Nikolaus
Title: Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive Cord-id: g8te7yhc Document date: 2020_10_14
ID: g8te7yhc
Snippet: -. There is a great need to swiftly develop vaccines and treatments against COVID-19 in the current pandemic. Yet, the time pressure and difficult circumstances to conduct clinical trials increases the risk of incomplete data sets, suboptimal study designs, and thus spurious results and reversals of decisions. -. Open access to clinical trial and other patient-relevant data is necessary in order to provide transparency, and the possibility for validating clinical-trial analyses, and fully exploi
Document: -. There is a great need to swiftly develop vaccines and treatments against COVID-19 in the current pandemic. Yet, the time pressure and difficult circumstances to conduct clinical trials increases the risk of incomplete data sets, suboptimal study designs, and thus spurious results and reversals of decisions. -. Open access to clinical trial and other patient-relevant data is necessary in order to provide transparency, and the possibility for validating clinical-trial analyses, and fully exploiting the information emerging from clinical trials. Thus, open access is critical in order to enable the successful and swift development of an effective intervention.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date